BMS?

Discussion in 'Shire' started by Anonymous, Mar 1, 2013 at 4:50 PM.

  1. Anonymous

    Anonymous Guest

    Something is going on - hope this is not it
     
  2. Anonymous

    Anonymous Guest

    To much chatter and to much need for multiple pharma companys to make an acquisition. Seems as if the organization might even be staging itself for a take over...Of the rumors out there BMS would be the best for CNS as they have little to no sales force and products in CNS now.
     
  3. Anonymous

    Anonymous Guest

    A buyout isn't going to happen, and I'm not blind to the rumors and speculation. Stop reading the rumor mill shit on the financial sector. Flemming is a totally different CEO than Angus, and that's not a shot at AR either. Flemming is talking about Shire making acquisitions rather than being acquired. I know if someone came through with deep pockets it could happen, but I just don't see it.

    But, if I read the crap that you all read all day long INSTEAD OF WORKING, maybe is feel differently.
     
  4. Anonymous

    Anonymous Guest

    Shire will be bought! Mark my words. Just keep driving. I am glad you know the new CEO so well also. How much kool aid did you drink before posting this?
     
  5. Anonymous

    Anonymous Guest

    The funny thing is that you have no idea who I am, yet you make statements like you do. Typical CafePharma idiot. If anyone posts anything that isn't bitching about their job, worrying about a buyout, or worrying about being tracked on their iPads they've either drank the Kool-Aid or they're an RD. Get a grip.
     
  6. Anonymous

    Anonymous Guest

    Hope your right. The presidents from every division and the CEO all leave in less than a year - causes some skepticism. Many of us have come from other companies who lived through this before - and see the signs as all to familiar
     
  7. Anonymous

    Anonymous Guest

    I think if AR hadn't left, it would have happened. But not now. Shire has been on the rumor mill to be bought for no less than 5 years.
     
  8. Anonymous

    Anonymous Guest

    BMS no CNS? What about Abilify - one of the largest products in the world. They have no GI and no rare disease treatments. CNS they have.
     
  9. Anonymous

    Anonymous Guest

    Wrong. Ability is otsuka only now
     
  10. Anonymous

    Anonymous Guest

    What difference does it make who buys us? We are already run by big pharma rejects who were discarded from their big pharma jobs. We have so many tracking tools, processes, procedures, policies that are all from big pharma companies.

    If we do get bought I hope they drive out the current leadership
     
  11. Anonymous

    Anonymous Guest

    Although I realize that most will read this and call BS, that's what's going to happen here. Trust me.
     
  12. Anonymous

    Anonymous Guest

    No idiot who comes onto Cafe Pharma knows any info on BMS or AZ.
     
  13. Anonymous

    Anonymous Guest

    They lost abilify and they need something to replace that product. Vyvanse fits!! Sorry shire.
     
  14. Anonymous

    Anonymous Guest

    Y'all deserve to get bought out and fired!! BMS no longer has a NSS division at all. They laid them all off in November. AZ and BMS together will buy you before the end of the year. You will be brought on for 6 months and then shown the door. Just ask Amylin.
     
  15. Anonymous

    Anonymous Guest

    Not a chance
     
  16. Anonymous

    Anonymous Guest

    Said the Supernus troll
     
  17. Anonymous

    Anonymous Guest

    Said the jilted Amylin rep who was laid off. Everyone here is aware of the rumors. The SAME rumors that we've been hearing for years. Spend less time on CP trying to instill fear and more time finding a job. I think you'll find yourself feeling a little better.
     
  18. Anonymous

    Anonymous Guest

    Is this the week?
     
  19. Anonymous

    Anonymous Guest

    I heard Supernus may buy us
     
  20. Anonymous

    Anonymous Guest

    Lol, Supernus couldn't afford a 1 month prescription of Vyvanse, even with the $30 copay card.
     

Share This Page